Molecule intelOpportunity: StrongEssential

Fluphenazine

26 brands · 19 companies · product forms

ATC: N05AB02 1 DRAP alert

Opportunity snapshot

Launch attractiveness
59
Market saturation
49
Price room
100
Regulatory risk
50
26
brands
19
companies
Rs 146.44
median price
14
price points
26.71x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 12%

Price room

Across observed sources and strengths
CheapestRs 38
MedianRs 146.44
Most expensiveRs 1,015.04
Spread26.71×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 26.71x across 14 trusted points (Rs 38.0-1015.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Fluphenazine — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2025-02-18
Recall Alert: Voluntary Recall of 36 Batches of Motival Tablets (Reg # 004539) Manufacture

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(51) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

19 canonical companies and 26 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 26.71x across 14 trusted points (Rs 38.0-1015.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2025-02-18 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.